You are here

Article info

Article menu

Download PDFPDF

XML
Immune cell therapies and immune cell engineering
Original research
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency

Authors

  • Feng Li Biotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China Cancer Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA PubMed articlesGoogle scholar articles
  • Yuqiao Sheng Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA Medical Research Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China PubMed articlesGoogle scholar articles
  • Weizhou Hou Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA PubMed articlesGoogle scholar articles
  • Padma Sampath Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA PubMed articlesGoogle scholar articles
  • Daniel Byrd Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA PubMed articlesGoogle scholar articles
  • Stephen Thorne Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA PubMed articlesGoogle scholar articles
  • Yi Zhang Biotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China Cancer Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China PubMed articlesGoogle scholar articles

Citation

Li F, Sheng Y, Hou W, et al
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
Journal for ImmunoTherapy of Cancer 2020;8:e000131. doi: 10.1136/jitc-2019-000131
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.